Location: Miami, FL
CIK: 0001937964 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 17, 2026
Total Value: $706M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| INSM | INSMED INC | 682,212 | $119M | 16.8% | $72.29 | +152.4% | COM PAR $.01 | 457669307 |
| ABVX | ABIVAX SA | 600,747 | $81.01M | 11.5% | $116.11 | — | SPONSORED ADS | 00370M103 |
| INSM | INSMED INC | 420,000 | $73.1M | 10.4% | $72.29 | +152.4% | Put | 457669307 |
| ARGX | ARGENX SE | 64,699 | $54.41M | 7.7% | $527.57 | — | SPONSORED ADR | 04016X101 |
| LLY | ELI LILLY & CO | 50,500 | $54.27M | 7.7% | $882.32 | +8.3% | COM | 532457108 |
| VKTX | VIKING THERAPEUTICS INC | 719,365 | $25.31M | 3.6% | $34.07 | +4.0% | COM | 92686J106 |
| TRVI | TREVI THERAPEUTICS INC | 2,013,602 | $25.21M | 3.6% | $6.66 | +73.5% | COM | 89532M101 |
| SLNO | SOLENO THERAPEUTICS INC | 533,698 | $24.71M | 3.5% | $55.51 | -1.2% | COM | 834203309 |
| UGL | PROSHARES TR II | 442,119 | $24.55M | 3.5% | $46.06 | — | ULTRA GOLD | 74347W601 |
| QURE | UNIQURE NV | 1,023,539 | $24.49M | 3.5% | $25.44 | +51.7% | SHS | N90064101 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 503,936 | $17.68M | 2.5% | $31.28 | +16.3% | ORDINARY SHARES | N62509109 |
| AZN | ASTRAZENECA PLC | 190,752 | $17.54M | 2.5% | $69.76 | — | SPONSORED ADR | 046353108 |
| — | CIDARA THERAPEUTICS INC | 70,824 | $15.64M | 2.2% | $220.89 | — | COM NEW | 171757206 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 767,098 | $14.01M | 2.0% | $11.20 | +26.5% | COM NEW | 30233G209 |
| IONS | IONIS PHARMACEUTICALS INC | 144,376 | $11.42M | 1.6% | $64.26 | +17.2% | COM | 462222100 |
| DNTH | DIANTHUS THERAPEUTICS INC | 205,090 | $8.452M | 1.2% | $31.76 | +22.1% | COM | 252828108 |
| RVMD | REVOLUTION MEDICINES INC | 104,190 | $8.299M | 1.2% | $48.13 | +36.2% | COM | 76155X100 |
| DGX | QUEST DIAGNOSTICS INC | 40,817 | $7.083M | 1.0% | $165.04 | +10.3% | COM | 74834L100 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 17,400 | $6.919M | 1.0% | $280.16 | +58.0% | COM | 02043Q107 |
| VTYX | VENTYX BIOSCIENCES INC | 695,982 | $6.285M | 0.9% | $7.47 | 0.0% | COM | 92332V107 |
| PVLA | PALVELLA THERAPEUTICS INC NE | 59,200 | $6.196M | 0.9% | $85.31 | 0.0% | COM | 697947109 |
| UGL | PROSHARES TR II | 100,000 | $5.552M | 0.8% | $46.06 | — | Put | 74347W601 |
| MLYS | MINERALYS THERAPEUTICS INC | 137,800 | $5.001M | 0.7% | $30.39 | +32.0% | COM | 603170101 |
| SION | SIONNA THERAPEUTICS INC | 119,741 | $4.926M | 0.7% | $37.92 | 0.0% | COM | 829401108 |
| PALI | PALISADE BIO INC | 1,992,367 | $4.682M | 0.7% | $1.92 | 0.0% | COM | 696389402 |
| RNAM | AVIDITY BIOSCIENCES INC | 60,100 | $4.335M | 0.6% | $37.09 | +74.2% | COM | 05370A108 |
| SRRK | SCHOLAR ROCK HLDG CORP | 96,285 | $4.241M | 0.6% | $38.47 | -2.5% | COM | 80706P103 |
| RAPP | RAPPORT THERAPEUTICS INC | 138,508 | $4.202M | 0.6% | $23.09 | +19.9% | COM | 75383L102 |
| PROK | PROKIDNEY CORP | 1,838,411 | $4.118M | 0.6% | $2.63 | 0.0% | SHS CL A | 74291D104 |
| ASND | ASCENDIS PHARMA A/S | 17,740 | $3.783M | 0.5% | $176.21 | — | SPONSORED ADR | 04351P101 |
| ABBV | ABBVIE INC | 14,500 | $3.313M | 0.5% | $182.67 | +24.6% | COM | 00287Y109 |
| BLTE | BELITE BIO INC | 17,989 | $2.878M | 0.4% | $159.96 | — | SPONSORED ADS | 07782B104 |
| ROIV | ROIVANT SCIENCES LTD | 129,800 | $2.817M | 0.4% | $19.73 | 0.0% | SHS | G76279101 |
| TVTX | TRAVERE THERAPEUTICS INC | 70,700 | $2.701M | 0.4% | $27.18 | +19.7% | COM | 89422G107 |
| DRUG | BRIGHT MINDS BIOSCIENCES INC | 33,407 | $2.607M | 0.4% | $66.83 | 0.0% | COM NEW | 10919W405 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 5,000 | $2.436M | 0.3% | $342.70 | +35.9% | COM | 91307C102 |
| SLNO | SOLENO THERAPEUTICS INC | 50,000 | $2.315M | 0.3% | $55.51 | -1.2% | Call | 834203309 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 22,951 | $2.005M | 0.3% | $36.55 | +123.9% | COM | 74366E102 |
| UPB | UPSTREAM BIO INC | 68,653 | $1.864M | 0.3% | $24.89 | 0.0% | COM | 91678A107 |
| XENE | XENON PHARMACEUTICALS INC | 40,000 | $1.793M | 0.3% | $46.00 | -8.7% | COM | 98420N105 |
| OCUL | OCULAR THERAPEUTIX INC | 141,061 | $1.712M | 0.2% | $11.96 | +1.6% | COM | 67576A100 |
| BBIO | BRIDGEBIO PHARMA INC | 20,400 | $1.56M | 0.2% | $48.77 | +34.6% | COM | 10806X102 |
| BTSG | BRIGHTSPRING HEALTH SVCS INC | 41,600 | $1.558M | 0.2% | $23.24 | +44.3% | COM | 10950A106 |
| PEPG | PEPGEN INC | 205,324 | $1.337M | 0.2% | $5.19 | 0.0% | COM | 713317105 |
| ABVX | ABIVAX SA | 9,900 | $1.335M | 0.2% | $116.11 | — | Call | 00370M103 |
| CELC | CELCUITY INC | 12,900 | $1.287M | 0.2% | $82.21 | 0.0% | COM | 15102K100 |
| KNSA | KINIKSA PHARMACEUTICALS INTL | 29,200 | $1.204M | 0.2% | $25.46 | +57.6% | ORD SHS CL A | G52694109 |
| OCUL | OCULAR THERAPEUTIX INC | 85,200 | $1.034M | 0.1% | $11.96 | +1.6% | Call | 67576A100 |
| NUVL | NUVALENT INC | 8,100 | $815K | 0.1% | $98.60 | 0.0% | COM | 670703107 |
| AVTX | AVALO THERAPEUTICS INC | 41,570 | $755K | 0.1% | $16.88 | 0.0% | COM NEW | 05338F306 |
| PRAX | PRAXIS PRECISION MEDICINES I | 2,500 | $737K | 0.1% | $186.22 | 0.0% | COM NEW | 74006W207 |
| ANRO | ALTO NEUROSCIENCE INC | 29,192 | $520K | 0.1% | $12.59 | 0.0% | COM SHS | 02157Q109 |
| TENX | TENAX THERAPEUTICS INC | 42,080 | $513K | 0.1% | $8.70 | 0.0% | COM NEW | 88032L605 |
| KOD | KODIAK SCIENCES INC | 17,019 | $476K | 0.1% | $20.48 | 0.0% | COM | 50015M109 |
| LYRA | LYRA THERAPEUTICS INC | 8,756 | $26,968 | 0.0% | $4.98 | 0.0% | COM NEW | 55234L204 |